雜志介紹

Lancet雜志介紹

《Lancet》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱柳葉刀，本刊主要出版、報道醫(yī)學-MEDICINE, GENERAL & INTERNAL領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領域相關(guān)學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為98.4，最新CiteScore 指數(shù)為148.1。

本刊近期中國學者發(fā)表的論文主要有：

• Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

  Author: Hurvitz, Sara A.; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, Jose Manuel; Kim, Sung-Bae; Petry, Vanessa; Huang, Chiun-Sheng; Li, Wei; Frenel, Jean-Sebastien; Antolin, Silvia; Yeo, Winnie; Bianchini, Giampaolo; Loi, Sherene; Tsurutani, Junji; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortes, Javier

• Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferioritytrial

  Author: Wang, Yongjun; Li, Shuya; Pan, Yuesong; Li, Hao; Parsons, Mark W.; Campbell, Bruce C., V; Schwamm, Lee H.; Fisher, Marc; Che, Fengyuan; Dai, Hongguo; Li, Deyang; Li, Runhui; Wang, Junhai; Wang, Yilong; Zhao, Xingquan; Li, Zixiao; Zheng, Huaguang; Xiong, Yunyun; Meng, Xia

• Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis

  Author: Pan, Yang; Wang, Liang; Feng, Zhaomin; Xu, Hui; Li, Fu; Shen, Ying; Zhang, Daitao; Liu, William J.; Gao, George F.; Wang, Quanyi

• Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

  Author: Kimball, Alexa B.; Jemec, Gregor B. E.; Alavi, Afsaneh; Reguiai, Ziad; Gottlieb, Alice B.; Bechara, Falk G.; Paul, Carle; Bourboulis, Evangelos J. Giamarellos; Villani, Axel P.; Schwinn, Andreas; Rueff, Franziska; Ramaya, Larisha Pillay; Reich, Adam; Lobo, Ines; Sinclair, Rodney; Passeron, Thierry; Martorell, Antonio; Mendes-Bastos, Pedro; Kokolakis, Georgios; Becherel, Pierre-Andre; Wozniak, Magdalena B.; Martinez, Angela Llobet; Wei, Xiaoling; Uhlmann, Lorenz; Passera, Anna; Keefe, Deborah; Martin, Ruvie; Field, Clarice; Chen, Li; Vandemeulebroecke, Marc; Ravichandran, Shoba; Muscianisi, Elisa

英文介紹

Lancet雜志英文介紹

The Lancet is an international general medical journal that will consider any original contribution that advances or illuminates medical science or practice, or that educates or entertains the journal's readers. Whatever you have written, remember that it is the general reader whom you are trying to reach. One way to find out if you have succeeded is to show your draft to colleagues in other specialties. If they do not understand, neither, very probably, will The Lancet's staff or readers. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal.